Trial Search Results

Closed-loop Optimized rTMS for Depression

Targeted and individualized treatments for mental health disorders are critically needed. Repetitive transcranial magnetic stimulation (rTMS) represents the front-line of new and innovative approaches to normalizing dysfunctional brain networks in those with mental illness. rTMS is FDA-approved for depression and obsessive-compulsive disorder with clinical trials underway for PTSD and addiction, among others. However, remission rates are suboptimal and ideal stimulation parameters are unknown. We recently completed a randomized, double blind clinical trial and a depression severity biomarker that predicts clinical outcome. The overarching goal of this study is to develop the first broadly generalizable platform for real-time biomarker monitoring and personalized rTMS treatment. We plan to recruit patients with medication-resistant depression and in perform a four-phase, cross-over, double-blind, placebo-controlled trial to 1) identify how standard and optimized rTMS patterns engage the depression severity biomarker, and 2) determine the dose-response of these rTMS patterns. Findings from this study will provide the basis for a double-blind, randomized clinical trial comparing rTMS optimized to the individual against standard rTMS.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Device: closed-loop rTMS
  • Device: open-loop rTMS
  • Device: sham rTMS

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Men and women, ages 18 to 65

   - Depression assessed through phone screen

   - Not currently on antidepressant medications

   - Must comprehend English well to ensure adequate comprehension of the EEG and TMS
   instructions, and of clinical scales

   - Right-handed

   - No current or history of neurological disorders

   - No seizure disorder or risk of seizures

   - No use of PRN medication within 48 hours of the scheduled study appointment

Exclusion Criteria:

   - Those with a contraindication for MRIs (e.g. implanted metal)

   - Any unstable medical condition

   - History of head trauma with loss of consciousness

   - History of seizures

   - Neurological or uncontrolled medical disease

   - Active substance abuse

   - Diagnosis of psychotic or bipolar disorder

   - A prior history of ECT or rTMS failure

   - Currently taking medications that substantially reduce seizure threshold (e.g.,
   olanzapine, chlorpromazine, lithium)

   - Currently pregnant or breastfeeding

Ages Eligible for Study

18 Years - 65 Years

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Jade Truong
Recruiting